January 11, 2022
New Study Finds Neurons Derived from Stem Cells Predict Psychosis and Cognitive Deficits in Individuals with Schizophrenia
Findings open door to personalized medicine, with the potential to predict the onset of schizophrenia — and the severity of symptoms — well before the first psychotic episode.
Learn MoreNovember 08, 2021
New Study Finds Genes and Air Pollution Multiply Healthy People’s Risk of Depression
Neuroscientists at the Lieber Institute for Brain Development and at Peking University in Beijing reveal how air pollution and genes join forces to affect brain circuitry, increasing depression risk
Learn MoreMarch 16, 2021
Boehringer Ingelheim and The Lieber Institute for Brain Development to Collaborate to Develop Centrally Acting COMT Inhibitors for Treatment of Neuropsychiatric Disorders
• Through the partnership with the Lieber Institute, Boehringer Ingelheim obtains access to preclinical pipeline candidates of a potential first-in-class approach for the symptomatic treatment of neuropsychiatric disorders, including schizophrenia. • The new collaboration further expands Boehringer Ingelheim’s circuitry-based approach […]
Learn MoreSeptember 25, 2020
LIBD in the News: NPR’s All Things Considered
The full story from Jon Hamilton aired September 24, 2020.
Learn MoreA statement from the
Lieber Institute:
Genes and Behavior
